Unit­ed Ther­a­peu­tics tran­si­tions to pub­lic ben­e­fit cor­po­ra­tion more than 20+ years af­ter IPO

Unit­ed Ther­a­peu­tics has been a pub­lic com­pa­ny since 1999, but late Thurs­day the com­pa­ny an­nounced it’s en­ter­ing a new phase.

Unit­ed will be­come a pub­lic ben­e­fit cor­po­ra­tion in what the com­pa­ny claims is the first con­ver­sion of a pub­lic biotech or phar­ma­ceu­ti­cal com­pa­ny to PBC, Unit­ed said. The biotech not­ed it has pre­vi­ous ex­pe­ri­ence in the PBC world, hav­ing run a sub­sidiary as a pub­lic ben­e­fit cor­po­ra­tion for the past six years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER